Related Experiment Video
Updated: Oct 25, 2025

08:51
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
1.6K
Prediction of Potential MicroRNA-Disease Association Using Kernelized Bayesian Matrix Factorization.
Ahmet Toprak1, Esma Eryilmaz Dogan2
1Department of Electricity and Energy, Bozkır Vocational School, Selcuk University, Bozkır, Konya, Turkey.
Interdisciplinary Sciences, Computational Life Sciences
|August 9, 2021
Summary
Kernelized Bayesian Matrix Factorization (KBMF) predicts microRNA-disease associations. This computational method aids disease diagnosis and treatment by identifying novel relationships, achieving high accuracy in case studies.
Area of Science:
- Bioinformatics
- Genomics
- Computational Biology
Background:
- MicroRNAs (miRNAs) are non-coding RNAs implicated in disease pathogenesis.
- Experimental identification of miRNA-disease associations is costly and time-consuming.
- Computational methods are essential for efficient prediction of these associations.
Purpose of the Study:
- To develop a computational model for predicting novel microRNA-disease associations.
- To leverage miRNA functional similarity, disease semantic similarity, and known interactions.
- To provide a reliable tool for understanding disease mechanisms and aiding clinical applications.
Main Methods:
- Kernelized Bayesian Matrix Factorization (KBMF) was employed.
- The method integrated multiple data sources including functional and semantic similarities.
- Fivefold cross-validation was used to evaluate performance.
Main Results:
- The KBMF technique achieved a high Area Under the Curve (AUC) value of 0.9450.
- Case studies on breast, lung, and colon neoplasms demonstrated the method's effectiveness.
- The results confirmed the predictive reliability of the KBMF approach.
Conclusions:
- KBMF is a robust computational model for inferring miRNA-disease associations.
- This approach facilitates the discovery of potential biomarkers for various diseases.
- The method offers a cost-effective alternative to experimental identification.
Related Concept Videos
MicroRNAs
3.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs
22.5K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.5K

